Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Forecasted Market Size Estimates For The Pelvic Inflammatory Disease (PID) Treatment Market Between 2025 And 2029?
The pelvic inflammatory disease (pid) treatment market size has demonstrated robust expansion in recent years. It is anticipated to expand from $4.49 billion in 2024 to $4.74 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.5%. The historical growth trajectory is largely a result of the burgeoning adoption of telemedicine, an escalating incidence of sexually transmitted infections, the increasing occurrence of sexually transmitted infection (STI) cases, heightened public awareness concerning pelvic inflammatory disease, and a general rise in healthcare expenditure.
The pelvic inflammatory disease (pid) treatment market is projected to experience robust expansion over the coming years. This market is set to reach $5.84 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.4%. The expansion during the forecast period is propelled by the increasing prevalence of sexually transmitted infections, rising awareness concerning women’s reproductive health, greater understanding of pelvic inflammatory disease, growing dependence on telehealth services, and the escalating incidence of sexually transmitted infections (STIs). Key trends anticipated during this period encompass novel pelvic inflammatory disease treatment products, progress in diagnostic technologies, developments like personalized treatment, sophisticated imaging methods, and overall technological improvements.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21251&type=smp
What Are The Main Drivers Boosting The Pelvic Inflammatory Disease (PID) Treatment Industry’s Expansion?
The growing incidence of sexually transmitted infections is anticipated to boost the pelvic inflammatory disease (PID) treatment market in the future. STIs, which are caused by bacteria, viruses, or parasites, are predominantly transmitted via sexual activities such as vaginal, anal, or oral sex. The rise in STI prevalence can be attributed to elements like risky sexual practices, unprotected intercourse, insufficient knowledge, and delays in testing and treatment. PID treatment plays a crucial role in addressing STIs by employing antibiotics to eradicate infectious bacteria, preventing issues like chronic pelvic pain and infertility, and lessening the likelihood of repeated infections. For instance, in October 2024, a report from the UK Health Security Agency (UKHSA), a UK government body, indicated that England registered 6,008 new human immunodeficiency virus (HIV) diagnoses in 2023, representing a 51% increase from the 3,975 diagnoses in 2022. Consequently, the increasing occurrence of sexually transmitted infections is propelling the expansion of the pelvic inflammatory disease (PID) treatment market.
What Are The Key Segments In The Pelvic Inflammatory Disease (PID) Treatment Market?
The pelvic inflammatory disease (pid) treatmentmarket covered in this report is segmented –
1) By Treatment Type: Antibiotic Therapy; Surgery; Pain Management; Hormonal Therapy
2) By Route Of Administration: Oral; Intravenous; Intramuscular
3) By End User: Hospitals; Clinics; Homecare
Subsegments:
1) By Antibiotic Therapy: Broad-spectrum Antibiotics; Combination Antibiotic Therapy; Oral Antibiotics; Intravenous Antibiotics
2) By Surgery: Laparoscopy; Hysterectomy; Tubal Surgery
3) By Pain Management: Nonsteroidal Anti-inflammatory Drugs (NSAIDs); Opioid Analgesics; Acetaminophen; Localized Pain Management
4) By Hormonal Therapy: Birth Control Pills; Hormonal Intrauterine Device (IUD); Progesterone Therapy
What Key Innovation Trends Are Fueling Advancements In The Pelvic Inflammatory Disease (PID) Treatment Market?
Companies active in the pelvic inflammatory disease (PID) treatment market are emphasizing innovative formulations, including probiotic supplements, to boost treatment effectiveness, restore the balance of vaginal microbiota, and decrease the reoccurrence of infections in patients with pelvic inflammatory disease (PID). A probiotic supplement is defined as a product containing beneficial live bacteria or yeasts that contribute to maintaining or re-establishing a healthy equilibrium of gut and vaginal microbiota. For example, in November 2024, Lee Health Domain, an India-based pharmaceutical company, introduced V-Ferin, a probiotic supplement developed to support vaginal health. This product, formulated with Lactobacillus acidophilus, lactoferrin peptide, and cranberry extract, seeks to restore the natural microbiome and prevent common vaginal infections like bacterial vaginosis and yeast infections. Considering that around 25-30% of women are affected by these conditions, which can potentially lead to pelvic inflammatory disease if left unaddressed, V-Ferin presents a novel solution to improve health and deter complications.
Who Are The Core Companies Influencing The Pelvic Inflammatory Disease (PID) Treatment Market Landscape?
Major companies operating in the pelvic inflammatory disease (PID) treatment market are Pfizer Inc., Bayer AG, Eli Lilly and Company, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Hetero Drugs Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Mankind Pharma Ltd., Mayne Pharma Group Limited, Saphnix Lifesciences, Aristo Pharmaceuticals Pvt. Ltd., Zydus Cadila Healthcare Ltd., Amagen India Life Sciences.
Download The Full Report For Exclusive Market Findings:
Which Region Is Projected To Lead The Pelvic Inflammatory Disease (PID) Treatment Market During The Forecast Period?
North America was the largest region in the pelvic inflammatory disease (PID) treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pelvic inflammatory disease (PID) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Pelvic Inflammatory Disease (PID) Treatment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=21251&type=smp
Browse Through More Reports Similar to the Global Pelvic Inflammatory Disease (PID) Treatment Market 2025, By The Business Research Company
Urinary Incontinence And Pelvic Organ Prolapse Devices And Equipment Global Market Report 2025
Inflammatory Bowel Disease Treatment Global Market Report 2025
Non Steroidal Anti Inflammatory Drugs Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model